Seeking Alpha | Sabrient Systems

SPYV: Cost-Efficient Exposure To Value Stock From The S&P 500

Thu, 02/12/2026 - 18:41

Oil prices retreat as IEA cuts 2026 oil demand forecast, still sees surplus

Thu, 02/12/2026 - 18:37

Ascopiave S.p.A. (ASCOF) Discusses Strategic Plan Focused on Gas Distribution, Renewable Energy, and Sustainable Growth - Slideshow

Thu, 02/12/2026 - 18:36

Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements

Thu, 02/12/2026 - 18:35

Bio-Rad Laboratories, Inc. 2025 Q4 - Results - Earnings Call Presentation

Thu, 02/12/2026 - 18:34

Expedia outlines 2026 revenue growth of 6%–9% with margin expansion as AI and B2B drive momentum

Thu, 02/12/2026 - 18:25

Bright Horizons targets $3.1B revenue and $5.10 EPS for 2026 while advancing portfolio rationalization

Thu, 02/12/2026 - 18:25

Expedia Group, Inc. 2025 Q4 - Results - Earnings Call Presentation

Thu, 02/12/2026 - 18:24

AVITA Medical, Inc. 2025 Q4 - Results - Earnings Call Presentation

Thu, 02/12/2026 - 18:14

Allspring Growth Fund Q4 2025 Commentary

Thu, 02/12/2026 - 18:12

NorthWestern outlines $3.21B capital plan and 5% EPS growth target as merger and data center deals advance

Thu, 02/12/2026 - 18:05

Lazard Emerging Markets Equity Portfolio Q4 2025 Commentary

Thu, 02/12/2026 - 18:00

Nabors Industries outlines 6%–8% normalized EBITDA growth for 2026 while expanding international rig count and reducing debt

Thu, 02/12/2026 - 17:45

Braskem plunges after Petrobras waives rights to potential share sale

Thu, 02/12/2026 - 17:38

Vornado Realty: Reviewing The 7%+ Preferreds After The Latest Earnings

Thu, 02/12/2026 - 17:37

Essential Properties outlines 2026 AFFO per share guidance growth up to 8% while capitalizing on resilient credit trends

Thu, 02/12/2026 - 17:35

YPF, Eni, Abu Dhabi's XRG sign development pact to advance Argentina LNG project

Thu, 02/12/2026 - 17:21

Suzano: Expecting Resumed Deleveraging In 2026

Thu, 02/12/2026 - 17:17

Ahold Delhaize: Defensive Compounder Approaching Fair Value

Thu, 02/12/2026 - 17:16

Karyopharm signals $130M–$150M revenue target for 2026 with pivotal myelofibrosis data readout ahead

Thu, 02/12/2026 - 17:15